Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab vs Ranibizumab in Retinal Vein Occlusion (BRVO)
NCT01635803Phase 3Unknown
- Sponsor
- University of Amsterdam
- Start
- Jun 2012
- Primary completion
- Jun 2016
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in retinal vein occlusion (RVO), macular edema, sponsored by University of Amsterdam. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
retinal vein occlusion (RVO)macular edema
Beyond the preview
Go deeper on NCT01635803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01635803.